Synchronous multifocality of newly diagnosed GBs and GB aggressiveness are partly linked to the invasion ability of neoplastic cells, resulting from an orchestrated activation of cell migration, in which EGFR plays a pivotal role [38, 43–45]. The gene discussed is EGFR; the disease is Guillain-Barre syndrome.